(MRNA) Moderna - Performance -80.4% in 12m
MRNA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-64.13%
#91 in Peer-Group
Rel. Strength
3.08%
#7228 in Stock-Universe
Total Return 12m
-80.44%
#179 in Peer-Group
Total Return 5y
-56.27%
#73 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 32.5 |
| High / Low | USD |
|---|---|
| 52 Week High | 137.60 USD |
| 52 Week Low | 23.65 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 73.17 |
| Buy/Sell Signal +-5 | 1.54 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: MRNA (-80.4%) vs XBI (-10.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.03% | 56.5% | 75.6% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-7.91% | -9.09% | 142% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-0.7% | -9.97% | 39.3% | 26.4 | 13.9 | 0.96 | 0.60% | 41% |
| BIM PA Biomerieux |
3.23% | 34.2% | 3.1% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
14.4% | 64.5% | -6.43% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
4.52% | -4.07% | -1.67% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
3.68% | 38.7% | -5.79% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.83% | 39.7% | 16.2% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: MRNA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MRNA
| Total Return (including Dividends) | MRNA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 0.15% | 5.71% | 2.95% |
| 3 Months | -21.57% | -5.62% | 6.01% |
| 12 Months | -80.44% | -10.55% | 13.19% |
| 5 Years | -56.27% | -23.79% | 117.19% |
| Trend Score (consistency of price movement) | MRNA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -30% | 56.6% | 78.3% |
| 3 Months | -9.4% | 38.4% | 84.6% |
| 12 Months | -97.1% | -82.3% | 43.3% |
| 5 Years | -53.8% | -52.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #129 | -5.26% | -2.72% |
| 3 Month | #145 | -16.90% | -26.02% |
| 12 Month | #179 | -78.13% | -82.72% |
| 5 Years | #73 | -42.62% | -79.86% |
FAQs
Does Moderna (MRNA) outperform the market?
No,
over the last 12 months MRNA made -80.44%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.55%.
Over the last 3 months MRNA made -21.57%, while XBI made -5.62%.
Performance Comparison MRNA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
MRNA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3% | -2.8% | -35% | -94% |
| US NASDAQ 100 | QQQ | 2.8% | -3.5% | -35.6% | -95% |
| German DAX 40 | DAX | 4% | 2.6% | -51.4% | -109% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.8% | -2.7% | -34.4% | -96% |
| Hongkong Hang Seng | HSI | 2.3% | -7.2% | -53.6% | -113% |
| India NIFTY 50 | INDA | 3.1% | -0.4% | -36.1% | -81% |
| Brasil Bovespa | EWZ | 5.4% | -1.7% | -58.7% | -87% |
MRNA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.9% | -3.5% | -40.1% | -106% |
| Consumer Discretionary | XLY | 2.2% | 0.5% | -25.9% | -100% |
| Consumer Staples | XLP | 3.2% | 0.7% | -37.1% | -87% |
| Energy | XLE | 8.3% | -3.4% | -35.4% | -77% |
| Financial | XLF | 1.9% | -1.5% | -39.5% | -106% |
| Health Care | XLV | 4.2% | -1.6% | -30.3% | -73% |
| Industrial | XLI | 2.8% | -1.4% | -42.2% | -100% |
| Materials | XLB | 3.9% | -0.9% | -37% | -80% |
| Real Estate | XLRE | 2.8% | -3.1% | -38.6% | -94% |
| Technology | XLK | 2.3% | -6.5% | -36.6% | -92% |
| Utilities | XLU | 2.6% | -0.5% | -41.6% | -101% |
| Aerospace & Defense | XAR | 3.2% | -4.2% | -52.7% | -123% |
| Biotech | XBI | 2.8% | -5.6% | -24.6% | -70% |
| Homebuilder | XHB | -0.9% | -1.7% | -26.4% | -76% |
| Retail | XRT | 3.3% | -1.2% | -29.6% | -83% |
MRNA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 16.2% | -8.35% | -32.6% | -72% |
| Natural Gas | UNG | 12.5% | 5% | -34.1% | -63% |
| Gold | GLD | 6.7% | -0.4% | -60.3% | -122% |
| Silver | SLV | 8.2% | -7.7% | -54.1% | -101% |
| Copper | CPER | 2.5% | -3.4% | -53.1% | -92% |
MRNA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.9% | -2.2% | -34.7% | -77% |
| iShares High Yield Corp. Bond | HYG | 4% | -1.3% | -37.9% | -90% |